General Notices

• Notice of Pre-application Webinar for NCI Funding Opportunity Announcement for RFA-CA-22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)"
  (NOT-CA-22-087)
  National Cancer Institute
  

• Notice of Pre-Application Webinars for the Maternal-Fetal Medicine Units Network and Neonatal Research Network Funding Opportunity Announcements
  (NOT-HD-22-023)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Nutrition as Prevention for Improved Cancer Health Outcomes
  (NOT-OD-22-138)
  Office of Disease Prevention
  

• Notice of Information that the Fogarty International Center (FIC) is participating in NOT-EB-22-001, "Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network Centers (U54 Clinical Trial Optional).
  (NOT-TW-22-002)
  John E. Fogarty International Center
  

• Promoting Equity in Global Health Research
  (NOT-TW-22-001)
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of NCCIH's Withdrawal from Participation in PAR-22-075, " NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
  (NOT-AT-22-024)
  National Center for Complementary and Integrative Health
  

• Notice to update Scored Review Criteria for PAR-22-108 "Innovative Ways to Provide Education on Antimicrobial Stewardship Practices in Animals (U01) Clinical Trial Not Allowed"
  (NOT-FD-22-010)
  Food and Drug Administration
  

• Notice of Change to Number of Applications per Institution Allowed for PAR-20-153 "NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)"
  (NOT-GM-22-037)
  National Institute of General Medical Sciences
  

• Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
  (NOT-HL-22-023)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Key Dates for RFA-OD-21-007 "INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)"
  (NOT-OD-22-120)
  Office of the Director, NIH
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)
  (NOT-AI-22-051)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
  (NOT-CA-22-038)
  National Cancer Institute
  Office of Disease Prevention
  

• Notice of Special Interest: Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus
  (NOT-NS-23-003)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest: Disease Mechanisms of Prenatal and Pediatric Hydrocephalus
  (NOT-NS-23-004)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  (NOT-OD-22-126)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data
  (NOT-PM-22-002)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

Funding Opportunities

• Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
  (PAR-22-186)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): December 07, 2024
  
  

• Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
  (RFA-DA-23-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 12, 2024
  
  

• Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional)
  (RFA-MH-22-180)
  National Institute of Mental Health
  Application Receipt Date(s): October 25, 2022
  
  

• NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional)
  (RFA-NS-22-036)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 08, 2024
  
  

• Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
  (RFA-NS-22-056)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 21, 2022
  
  

• Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-066)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 28, 2022